Focus: ImPact Biotech is a publicly traded Israeli biotech company specializing in photodynamic therapies (PDT) for oncology, headquartered in Ness Ziona. The company is in early-stage clinical development with a focused pipeline in novel cancer indications.
Profile data last refreshed 4h ago · AI intelligence enriched 2mo ago
Hot — 122 jobs added in 30d
Net +108 (122 new, 14 removed). Aggressive expansion phase.
ImPact Biotech presents a high-risk, early-stage opportunity best suited for scientists willing to bet on photodynamic therapy platform success with minimal near-term visibility.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for ImPact Biotech
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from ImPact Biotech's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo